Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|10|1305-1311

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.10, 2016-03, pp. : 1305-1311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 686-700

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 4936-4947

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Nicotinic Receptors for Parkinson's Disease Therapy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 651-658

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptors: A Therapeutic Target in the Structure Era

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-01 ,pp. : 695-706

Bentham Science Publishers

Access to resources Recommend Favorite

7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 121-129

Bentham Science Publishers

Access to resources Recommend Favorite